Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: Graft content and post transplant recovery predict survival

Bone Marrow Transplantation

Volumn 36, Issue 12, 2005, Pages 1049-1052

  Dean, R ^a   Masci, P ^a   Pohlman, B ^a   Andresen, S ^a   Serafino, S ^a   Sobecks, R ^a   Kuczkowski, E ^a   Curtis, J ^a   Maciejewski, J ^a   Rybicki, L ^b   Kalaycio, M ^a   Hsi, E ^a   Theil, K ^a   Bolwell, B J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Autologous bone marrow transplant; Dendritic cells; Diffuse large B cell lymphoma

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; BLOOD CELL COUNT; CANCER PATIENT; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; CELL TRANSPLANTATION; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; MALE; MIDDLE AGED; MODELS, STATISTICAL; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; STEM CELL TRANSPLANTATION; STEM CELLS; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 30544436594     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705183     Document Type: Article

References (16)

1. Caux C, Vanbervliet B, Massacrier C et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med 1996; 184: 695-706.
2. Robinson SP, Patterson S, English N et al. Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol 1999; 29: 2769-2778.
3. O'Doherty U, Peng M, Gezelter S et al. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 1994; 82: 487-493.
4. O'Neill DW, Adams S, Bhardwaj N. Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood 2004; 104: 2235-2246.
5. Rissoan MC, Soumelis V, Kadowaki N et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999; 283: 1183-1186.
6. Parmiani G, Castelli C, Dalerba P et al. Cancer immunotherapy with peptide-based vaccines: What have we achieved? Where are we going? J Natl Cancer Inst 2002; 94: 805-818.
7. Waller EK, Rosenthal H, Jones TW et al. Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation. Blood 2001; 97: 2948-2956.
8. Savary CA, Grazziutti ML, Melichar B et al. Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patients. Cancer Immunol Immunother 1998; 45: 234-240.
9. Fearnley DB, Whyte LF, Carnoutsos SA et al. Monitoring human blood dendritic cell numbers in normal individuals and in stem cell transplantation. Blood 1999; 93: 728-736.
10. Damiani D, Stocchi R, Masolini P et al. Dendritic cell recovery after autologous stem cell transplantation. Bone Marrow Transplant 2002; 30: 261-266.
11. Bolwell B, Sobecks R, Pohlman B et al. Etoposide (VP-16) plus G-CSF mobilizes different dendritic cell subsets than does G-CSF alone. Bone Marrow Transplant 2003; 31: 95-98.
12. Zhang H. Recursive Partitioning in the Health Sciences. Springer: New York, NY, 1999.
13. Siena S, Schiavo R, Pedrazzoli P, Carlo-Stella C. Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy. J Clin Oncol 2000; 18: 1360-1377.
14. Porrata LF, Litzow MR, Inwards DJ et al. Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma. Bone Marrow Transplant 2004; 33: 291-298.
15. DeAngelo DJ, Alyea EP, Borrello IM et al. Posttransplant immunotherapy with a GM-CSF-based tumor vaccine (GVAX®) following autologous stem cell transplant (ASCT) for acute myeloid leukemia (AML). Session Type: Oral Session. Blood 2004; 104: 441 (abstract).
16. Kronin V, Winkel K, Suss G et al. A subclass of dendritic cells regulates the response of naive CD8T cells by limiting their IL-2 production. J Immunol 1996; 157: 3819-3827.